ORIGINAL RESEARCH
Published on 19 Nov 2025
Metformin enhances alpelisib sensitivity in HER2+ breast cancer by suppressing cancer stemness and oncogenic signaling
doi 10.3389/fonc.2025.1631415
- 874 views
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Adapting Drug Repurposing to Drug Resistance in Cancer Volume II: Developing Synergistic Combinations
Adapting Drug Repurposing to Drug Resistance in Cancer Volume II: Developing Synergistic Combinations
4,119
Total downloads
19k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 08 Oct 2025
Case report: Anlotinib plus oral etoposide: a potential salvage therapy based on insights from EGFR-TKI-resistant SCLC transformation PDX and clinical settings
doi 10.3389/fonc.2025.1661273
- 1,156 views
- 1 citation
ORIGINAL RESEARCH
Published on 01 Sep 2025
Integrated transcriptomic analysis identifies lactylation-linked gemcitabine resistance and therapeutic targets in intrahepatic cholangiocarcinoma
doi 10.3389/fcell.2025.1611434
- 2,009 views
ORIGINAL RESEARCH
Published on 30 May 2025
Evaluating the multitargeted potency of Pixuvri against cell cycle regulation proteins in cervical cancer
doi 10.3389/fonc.2025.1598883
- 1,242 views
REVIEW
Published on 22 Jan 2025
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
doi 10.3389/fonc.2024.1502185
- 3,064 views
- 1 citation
CASE REPORT
Published on 22 Jan 2025
Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report
doi 10.3389/fonc.2024.1503262
- 1,451 views
CASE REPORT
Published on 11 Dec 2024
Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features
doi 10.3389/fonc.2024.1453895
- 1,868 views
- 4 citations
REVIEW
Published on 15 May 2024
Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy
doi 10.3389/fcell.2024.1369597
- 4,028 views
- 11 citations
Published in
Frontiers in Cell and Developmental Biology
Cancer Cell Biology
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: